Tomlinson, Brian

Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation

Mahajan, A., Spracklen, C. N., Zhang, W., Ng, M. C. Y., Petty, L. E., Kitajima, H., Yu, G. Z., Rüeger, S., Speidel, L., Kim, Y. J., et al. (2022) · Nature Genetics

Genetic Associations and EpidemiologyGenetic Mapping and Diversity in Plants and Animals

Cited by 704

Genetic drivers of heterogeneity in type 2 diabetes pathophysiology

Suzuki, K., Hatzikotoulas, K., Southam, L., Taylor, H. J., Yin, X., Lorenz, K. M., Mandla, R., Huerta-Chagoya, A., Melloni, G. E. M., Kanoni, S., et al. (2024) · Nature

Genetic Associations and EpidemiologyGenetic Mapping and Diversity in Plants and Animals

Cited by 606

Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls

Platform, B. G., Flannick, J., DiscovEHR Collaboration, CHARGE, LuCamp, ProDiGY, GoT2D, ESP, SIGMA-T2D, T2D-GENES, et al. (2019) · Nature

Genetic Associations and EpidemiologyGenomics and Rare Diseases

Cited by 304

Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis

Tam, L.-S., Tomlinson, B., Chu, T. T., Li, T. K., & Li, E. K. (2007) · Clinical Rheumatology

Rheumatoid Arthritis Research and TherapiesAdipokines, Inflammation, and Metabolic Diseases

Cited by 197

Progression of diabetic kidney disease and trajectory of kidney function decline in Chinese patients with Type 2 diabetes

Jiang, G., Luk, A. O. Y., Tam, C. H. T., Xie, F., Carstensen, B., Lau, E. S. H., Lim, C. K. P., Lee, H. M., Ng, A. C. W., Ng, M. C. Y., et al. (2019) · Kidney International

Chronic Kidney Disease and DiabetesAcute Kidney Injury Research

Cited by 159

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation

Fruchart, J.-C., Santos, R. D., Aguilar-Salinas, C., Aikawa, M., Al Rasadi, K., Amarenco, P., Barter, P. J., Ceska, R., Corsini, A., Després, J.-P., et al. (2019) · Cardiovascular Diabetology

Peroxisome Proliferator-Activated ReceptorsLipoproteins and Cardiovascular Health

Cited by 140

An evaluation of liraglutide including its efficacy and safety for the treatment of obesity

Lin, C.-H., Shao, L., Zhang, Y.-M., Tu, Y.-J., Zhang, Y., Tomlinson, B., Chan, P., & Liu, Z. (2020) · Expert Opinion on Pharmacotherapy

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 65

Health Promotion in Older Chinese: A 12-Month Cluster Randomized Controlled Trial of Pedometry and “Peer Support”

THOMAS, G. N., MACFARLANE, D. J., GUO, B., CHEUNG, B. M. Y., MCGHEE, S. M., CHOU, K.-L., DEEKS, J. J., LAM, T. H., & TOMLINSON, B. (2012) · Medicine & Science in Sports & Exercise

Physical Activity and HealthBalance, Gait, and Falls Prevention

Cited by 62

Investigational glucagon-like peptide-1 agonists for the treatment of obesity

Tomlinson, B., Hu, M., Zhang, Y., Chan, P., & Liu, Z.-M. (2016) · Expert Opinion on Investigational Drugs

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 25

An evaluation of the pharmacokinetics of inclisiran in the treatment of atherosclerotic cardiovascular disease

Tomlinson, B., Chow, E., Chan, P., & Lam, C. W. K. (2021) · Expert Opinion on Drug Metabolism & Toxicology

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 15